ALPHASCIENCE

Your aesthetic procedures activate the remodeling. Your patient's cells do the rebuilding.

Biostimulators and energy-based devices deliver the signal, but the response depends on cellular capacity. Oxidative load, mitochondrial fatigue and senescence quietly cap the magnitude of any remodeling procedure, whatever the technology. Think of it as renovating a house with an exhausted crew: the blueprint is perfect, the ex*****on falls short.

NOVACELL [Cg] works on the crew. Used as a primer 2 to 4 weeks before the treatment and as a daily amplifier after, it supports collagen synthesis, ATP production and matrix integrity.

🇫🇷 Formulated and made in France.

Pigmentation disorders don't behave the same way across skin tones : understanding why is central to treating them well.

The reason isn't a difference in melanocyte count: it's reactivity.
In darker skin, melanocytes produce more melanin in response to a trigger: UV, hormonal shifts and inflammation, especially post-injury. Think of it as a dimmer already set higher. The same signal that causes a mild reaction in fair skin produces a much stronger pigment response in darker skin.

From phototype III, melasma becomes more frequent. Further along the spectrum, post-inflammatory hyperpigmentation (PIH) becomes the dominant risk.

This is also why many classic depigmenting actives can backfire on these skin tones. High-dose hydroquinone, aggressive peels, and strong retinoids all carry a higher irritation potential. On more reactive skin, that irritation becomes a trigger of its own, feeding the same inflammation-pigmentation loop these treatments are initially meant to correct.

Cysteamine, the key active molecule in MELA BRIGHT [C+] takes a different route and doesn't feed inflammatory triggers. Its tolerance profile holds up consistently across phototypes, including the more reactive skin tones. Because safe and potent is what darker skin tones need !

MELA BRIGHT [C+] has become part of the post-laser protocol for many practitioners treating melasma and stubborn pigmentation.

Its cysteamine-based formula acts on multiple depigmenting pathways, but also targets the inflammatory cascade that follows laser treatment, creating a cutaneous environment less prone to the kind of inflammation-driven rebound that can compromise post-procedure results.

Applied daily for one month before and after the session, alongside SPF50, it supports the skin through the highest-risk window for relapse, and continues to help maintain results well beyond it: a protocol now documented across the two leading laser types used to treat stubborn pigmentation disorders, with consistent outcomes.

Melasma isn't just a spot to erase. It is a chronic condition that responds to a consistent pigment controlling and barrier-respecting routine. 🛡

Discover our 5 simple steps and extra tips to keep your melasma under control !

Sun protection is non-negotiable: no depigmenting active works without it. And since visible light also activates melasma-prone skin, a tinted product with iron oxides adds protection sunscreen alone can't. ☀

Consistency, not intensity, makes the difference.

When dermatologists and plastic surgeons across the world reach for the same serum for their melasma patients, it says something. MELA BRIGHT [C+] is trusted in clinical practice by the professionals who treat complex pigmentation every day.

Melasma control comes down to two things: consistency, and the right treatment.

As it's not a simple dark patch 🟤, but a state of chronic hyperreactivity 🔥in the melanocytes, it requires a formula that works at the epidermal, dermal and vascular levels at once. Acting on melanin alone leaves the triggers that feed recurrence untouched.
MELA BRIGHT [C+] addresses those pathways together with 3% cysteamine, pure L-ascorbic acid and ginkgo biloba. It's not an instant fix, but a long term partner in achieving a more even skin. And don’t forget to apply SPF50 !

If melasma can't be cured, it can be well controlled with the right routine.

Curious about the science? Mela Bright [C+] is worth a closer look.